Compounded semaglutide vs Ozempic
Last updated
Compounded semaglutide vs Ozempic: lowest prices now


Lowest compounded on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $76 a month over a year with the membership · first order: membership free for the first 21 days, never charged if you cancel before
Ozempic is FDA-approved semaglutide made by Novo Nordisk; compounded semaglutide is made by compounding pharmacies and is not FDA-approved. At the starting dose, the lowest self-pay prices are ≈ $213 per 30 days for Ozempic injection, $199/fill initially at NovoCare (Novo Nordisk); $149 per 30 days for Ozempic tablet, $149/30 days at NovoCare (Novo Nordisk). On a monthly plan, the lowest compounded semaglutide price is about $76 a month over a year with the membership: $59/mo + $199/yr membership at Collective. The lowest compounded semaglutide price that states its supply is ≈ $84 per 30 days: $78/mo at Sunlight.
Ozempic
FDA-approved · Novo Nordisk
Injection
Lowest self-pay, by dose
$199/fill initially (novocare.com/pharmacy/ozempic.html)28-day supply (novocare.com)
≈ $213.21 per 30 days at this quoted rate
Offer through
Checked on novocare.com
Ozempic pen
NovoCare (Novo Nordisk) · maker's own price
first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer for 2 monthly fills through December 31, 2026"
Price conditions
first two 28-day fills at 0.25 or 0.5 mg for new patients; NovoCare: "Offer for 2 monthly fills through December 31, 2026"
After the introductory offer: $349 per monthly fill for 0.25, 0.5, or 1 mg; $499 for 2 mg. NovoCare defines one injection fill as a 28-day supply. Introductory fills must ship by Jan 31, 2027. Eligibility and restrictions apply.
28-day supply
Tablet
Lowest self-pay, by dose
$149/30 days (novocare.com/pharmacy/ozempic.html)30-day supply (novocare.com)
$149 per 30 days at this quoted rate
Checked on novocare.com
Ozempic tablets
NovoCare (Novo Nordisk) · maker's own price
self-pay, 1.5 mg dose
Price conditions
self-pay, 1.5 mg dose
A prescription is required. A bottle of 30 tablets costs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg. Self-pay purchases are processed outside insurance and do not count toward deductibles or out-of-pocket limits.
30-day supply
Compounded semaglutide
Not FDA-approved · 462 sellers
Lowest with a stated supply
$78/mo (sunlight.com/lp_05)28-day supply (sunlight.com)
≈ $83.57 per 30 days at this quoted rate
Checked on sunlight.com
Compounded semaglutide via Sunlight
Sunlight · seller's own price
fall promotion, flat monthly rate locked in at enrollment, month to month; a 4-week supply each month; prescription, unlimited telehealth visits and shipping included
Price conditions
fall promotion, flat monthly rate locked in at enrollment, month to month; a 4-week supply each month; prescription, unlimited telehealth visits and shipping included
Sunlight's homepage shows the $78 promotion and, in its menu, semaglutide "Starting at $179" (read Nov 7, 2026; its weight-loss medications page, sunlight.com/weight-loss-medications, says "Sunlight semaglutide starts at $78 per month and tirzepatide at $139 per month."). The promotion states no end date. Compounded; not FDA-approved.
28-day supply
Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a product or a dose. GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.
Ozempic and compounded semaglutide compared
The same active ingredient, two different products. Prices are the sellers' own; the full lists are on each price page.
| Compare | Ozempic | Compounded semaglutide |
|---|---|---|
| What it is | FDA-approved semaglutide made by Novo Nordisk. | Semaglutide made by compounding pharmacies. Not FDA-approved, and not a generic of Ozempic. |
| FDA review | Reviewed and approved by the FDA for the uses on its label. | Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. The FDA had received 990 reports of adverse events associated with compounded semaglutide as of May 31, 2026. |
| Approved for |
| No approved use. |
| Forms | Injection (Once weekly); Tablet (Once daily, on an empty stomach) | Injection and tablets, as each seller lists them |
| Sellers with a price | 43 | 462 |
| Lowest price, starting dose |
| ≈ $84 per 30 days at Sunlight ($78/mo), the lowest of 98 quotes that state their supply |
| At the top published dose |
| $99/mo at 2.4 mg, from Lttl |
| Trial results | See its label | None that apply: a brand's trial results are for the brand. |
A lower price is not a like-for-like saving. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. It has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide, and says salt forms (such as semaglutide sodium) should not be used to compound it. FDA: concerns with unapproved GLP-1 drugs used for weight loss (fda.gov)
Compounded semaglutide vs Ozempic: common questions
Is compounded semaglutide the same as Ozempic?
No. Both contain semaglutide, but Ozempic is an FDA-approved product made by Novo Nordisk, and compounded semaglutide is made by compounding pharmacies, is not FDA-approved and is not a generic of Ozempic. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. It has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide, and says salt forms (such as semaglutide sodium) should not be used to compound it. FDA: concerns with unapproved GLP-1 drugs used for weight loss
Is compounded semaglutide cheaper than Ozempic?
At the starting dose, the lowest self-pay prices are ≈ $213 per 30 days for Ozempic injection, $199/fill initially at NovoCare (Novo Nordisk); $149 per 30 days for Ozempic tablet, $149/30 days at NovoCare (Novo Nordisk). On a monthly plan, the lowest compounded semaglutide price is about $76 a month over a year with the membership: $59/mo + $199/yr membership at Collective. The lowest compounded semaglutide price that states its supply is ≈ $84 per 30 days: $78/mo at Sunlight. At the top published dose, ≈ $535 per 30 days for Ozempic injection 2 mg, $499/28 days at NovoCare (Novo Nordisk); $299 per 30 days for Ozempic tablet 9 mg, $299/30 days at NovoCare (Novo Nordisk). The lowest compounded semaglutide top-dose price that states its supply is ≈ $106 per 30 days at 2.4 mg: $99/mo at Lttl. 462 sellers publish a price for compounded semaglutide and 43 publish one for Ozempic. They are different products, so a price gap does not make them interchangeable.
Is compounded semaglutide as effective as Ozempic?
Ozempic's approval rests on its own clinical trials. Those results are for Ozempic. The FDA does not review compounded drugs for effectiveness, so they do not carry over to a compounded product.
What is Ozempic approved for?
Injection: Adults with type 2 diabetes: glucose control; cardiovascular risk reduction with established cardiovascular disease; kidney and cardiovascular protection with chronic kidney disease. Tablet: Adults with type 2 diabetes: glucose control and cardiovascular risk reduction in those at high risk. The tablet label does not include the injection's kidney indication.
Can pharmacies still make compounded semaglutide?
The FDA declared the semaglutide shortage resolved in February 2025, which ended the exemption that let pharmacies make copies of the approved drug in bulk. Compounding is now generally limited to patient-specific prescriptions, and the FDA says compounded drugs should only be used for patients whose medical needs an FDA-approved drug cannot meet. No shortage is listed in the latest complete FDA check. The FDA does list discontinuation notices for specific presentations.